MedPath

Effect Of Vamana Karma(emesis) In The Management Of Obesity

Phase 2
Completed
Conditions
Health Condition 1: null- obese patient dyslipidemia
Registration Number
CTRI/2018/01/011573
Lead Sponsor
Rishikul Campus Uttarakhand Ayurved University Haridwar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

1.S.Cholesterol - > 200 mg/dl

2.S.Triglyceride - > 150 mg/dl

3.S. LDL - > 110 mg/dlNCEP

4.S.VLDL - > 41 mg/dlATP III Guidelines

5. CHO/HDL Ratio - >4.97 mg/dl

6.LDL/HDL Ratio - >3.55 mg/dl11

7.Patient having any one the above criteria

8.Patients fit for Vamana Karma

Exclusion Criteria

1.Age < 20 years or > 60 years

2.Patients having serious cardiac ailments as- Myocardial Infarction, malignant hypertension, cardiac failure.

3.Patients with clear diagnosis of DM Type I and type II.

4.Patients having disordered KFT or renal markers.

5.Patients having untreated Thyroid Disorders.

6.Drug induced Hyperlipidemia e.g. - Glucocorticoid induced.

7.Pregnant and lactating females.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Evaluatethe efficacy of Vamana Karma in the management of Dyslipidemia.Complete remission: 100% relief <br/ ><br>Markedly improvement:76-99% relief <br/ ><br>Moderately improvement: 51%-75% relief <br/ ><br>Mild Improvement: 26%-50% relief <br/ ><br>Unchanged: 25% relief <br/ ><br>Timepoint: 2 months <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
exacerbation in sign and symptomsTimepoint: 1 month
© Copyright 2025. All Rights Reserved by MedPath